CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China.
ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, China.
Front Immunol. 2023 Jan 19;14:1088501. doi: 10.3389/fimmu.2023.1088501. eCollection 2023.
infection is a severe public health concern with the growing number of multidrug-resistant strains. can circumvent the defense mechanisms of host immunity with the aid of multiple virulence factors. An efficacious multicomponent vaccine targeting diverse immune evasion strategies developed by is thus crucial for its infection control. In this study, we exploited the SpyCatcher-SpyTag system to engineer bacterial outer membrane vesicles (OMVs) for the development of a multitargeting click vaccine. We decorated OMVs with surface exposed SpyCatcher a truncated OmpA(a.a 1-155)-SpyCatcher fusion. The engineered OMVs can flexibly bind with various SpyTag-fused antigens to generate an OMV-based click vaccine. Compared with antigens mixed with alum adjuvant, the click vaccine simultaneously induced more potent antigen-specific humoral and Th1-based cellular immune response, which afforded protection against Newman lethal challenge in a mouse model. Our study provided a flexible and versatile click vaccine strategy with the potential for fighting against emerging clinical isolates.
感染是一个严重的公共卫生问题,越来越多的多药耐药菌株令人担忧。能够借助多种毒力因子规避宿主免疫的防御机制。因此,针对其感染控制,开发一种针对多种免疫逃避策略的有效多组分疫苗至关重要。在这项研究中,我们利用 SpyCatcher-SpyTag 系统对细菌外膜囊泡(OMV)进行工程化改造,以开发一种多靶向的点击疫苗。我们将表面暴露的 SpyCatcher 与截短的 OmpA(a.a 1-155)-SpyCatcher 融合物一起装饰在 OMV 上。工程化的 OMV 可以灵活地与各种 SpyTag 融合的抗原结合,从而产生基于 OMV 的点击疫苗。与与明矾佐剂混合的抗原相比,点击疫苗同时诱导了更强的抗原特异性体液和 Th1 细胞免疫应答,在小鼠模型中提供了针对 Newman 致命挑战的保护。我们的研究提供了一种灵活多样的点击疫苗策略,具有对抗新兴临床分离株的潜力。